Most Active Stocks

COCHINSHIP
BSE
SCI
INDIGO
JUBLINGREA
GRSE
BEL
HAL
RELIANCE
CDSL
MAZDOCK
ONGC
OIL
RPOWER
BDL
HDFCBANK
SBIN
JUBLPHARMA
GESHIP
INFY

Lupin Limited

Drug Manufacturers - Specialty & Generic | Healthcare

Company Overview

Lupin Limited, together with its subsidiaries, operates as a pharmaceutical company in India and internationally. It engages in the drug discovery, development, production, marketing, and sale of various branded and generic formulations, biosimilars, over-the-counter and specialty drugs, and active pharmaceutical ingredients (APIs). The company offers formulations for use in the therapeutic areas of anti-tuberculosis, diabetes management, cardiovascular, chronic obstructive pulmonary diseases, asthma, gynecology and women's health, central nervous system, oncology, immunology, genomics, metabolic disorders, dermatology, urology, pediatrics, gastrointestinal, anti-infective, and nonsteroidal anti-inflammatory drug therapies, as well as engages in the bio clinical research activities. It operates through network consists of labs, LupiMitra collection centers, and pick-up points. The company was formerly known as Lupin Chemicals Limited and changed its name to Lupin Limited in 2001. Lupin Limited was founded in 1968 and is headquartered in Mumbai, India.

Key Information

Market Cap

917363228672

Current Price

2008.7

52 Week Range

1543.0 - 2402.9

Previous Close

2004.8

Open

2012.9

Industry

Drug Manufacturers - Specialty & Generic

Sector

Healthcare

Contact Details

Address

Kalpataru Inspire, 3rd Floor Off. Western Expressway Highway Santacruz (East), Mumbai, 400055, India

Phone

+91-22664-02323

Fax

+91-22664-02051

Website

https://www.lupin.com

Financials

Day Low

2001.9

Day High

2023.0

Dividend Yield

0.4

PE Ratio

27.91024

Earnings Per Share

71.97

Beta

0.307

EBITDA

54966898688

Book Value

377.02

EPS

88.29433

Company Officers

Name Title Age Year Born
Ms. Vinita D. Gupta CEO & Executive Director 56 1968
Mr. Ramesh Swaminathan Executive Director, Global CFO, CRO & Head of API, Sustainability and IT 58 1966
Mr. Nilesh Deshbandhu Gupta MD & Executive Director 50 1974
Mr. Christoph Funke Chief Technical Operations Officer - -
Mr. Sreeji Gopinathan Chief Information Officer - -
Dr. Shahin Fesharaki President -Global Chief Scientific Officer - -
Mr. Ravi Agrawal Sr. Vice President of Investor Relations and M&A - -
Dr. Sofia Mumtaz President of Legal and Compliance of Australia, Japan & Canada Business - -
Mr. Amit Kumar Gupta Company Secretary & Compliance Officer - -
Ms. Rajalakshmi Azariah Vice President & Global Head of Corporate Communications - -

Company Details

Stock History

Explore More Stocks